Treatment of venous malformations: First experience with a new sclerosing agent – A multicenter study

Schumacher, Martin; Dupuy, P; Bartoli, Jean-Michel; Ernemann, Ulrike; Herbreteau, Denis; Ghienne, Corinne; Guibaud, Laurent; Loose, Dirk A.; Mattassi, Raul; Petit, Philippe; Rößler, Jochen; Stillo, Francesco; Weber, Johannes Heinrich

doi:10.1016/j.ejrad.2010.12.074

Cited by 29 publications

(13 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to Schumacher et al. , also, 77 patients underwent sclerotherapy using ethylcellulose ethanol in a multicenter study, and significant improvement compared with the pretreatment state was observed in all patients.…”

Section: Resultsmentioning

confidence: 90%

Japanese Clinical Practice Guidelines for Vascular Anomalies 2017

Mimura

Akita

Fujino

et al. 2020

The Journal of Dermatology

View full text Add to dashboard Cite

The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety and systematizing treatment, employing evidence-based medicine techniques and aimed at improvement of the outcomes. Clinical questions (CQ) were decided based on the important clinical issues. For document retrieval, key words for published work searches were set for each CQ, and work published from 1980 to the end of September 2014 was searched in PubMed, Cochrane Library and Japana Centra Revuo Medicina databases. The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System technique. A total of 33 CQ were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.

show abstract

Section: Resultsmentioning

confidence: 90%

Japanese Clinical Practice Guidelines for Vascular Anomalies 2017

Mimura

Akita

Fujino

et al. 2020

The Journal of Dermatology

View full text Add to dashboard Cite

show abstract

“…Concerning the use of ethanol, Suh et al [87] reported alleviation to 50% or less of the pre-treatment state according to a VAS in 12 (71%) of 17 patients who underwent sclerotherapy using its mixture with lipiodol, and Dompmartin et al [88] reported 37 patients who underwent sclerotherapy using its mixture with ethylcellulose. According to Schumacher et al [89], also, 77 patients underwent sclerotherapy using ethylcellulose-ethanol in a multicenter study, and significant improvement compared with the pre-treatment state was observed in all patients.…”

Section: Sclerotherapymentioning

confidence: 95%

Japanese clinical practice guidelines for vascular anomalies 2017

et al. 2020

View full text Add to dashboard Cite

The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.

show abstract

“…Another technique used by many authors is to use the ethanol in its gel form, also known as ethylcellulose ethanol. 6 The idea is to decrease the systemic side effect of ethanol by decreasing its diffusivity in the system. Since the gel is localized to the lesion, it can be used in VMs involving areas with higher risk of side effects such as hand or periorbital regions.…”

Section: Choice Of Sclerosantmentioning

confidence: 99%

Outcomes of Venous Malformation Sclerotherapy: A Review of Study Methodology and Long-Term Results

Ali

Mitchell

2017

Semin intervent Radiol

View full text Add to dashboard Cite

It is very important that patients seeking sclerotherapy for the treatment of venous malformations are aware of the expected course of the therapy. They should be thoroughly counseled about the complications, the need for multiple sessions of therapy, and also about the expected clinical outcome. The aim of this review is to discuss the long-term outcomes of sclerotherapy for the treatment of venous malformation. Many studies have discussed their individual center's experiences and short-midterm results, but there is a relative paucity of data on long-term outcomes. We have reviewed the literature and also shared our experience of a large cohort of patients ( = 116) with a relatively longer follow-up period of more than 1 year. Venous malformations are very complex lesions and their treatment is quite variable depending on its extent and complexity. As a result, outcome studies vary considerably in the choice of sclerosant, study methodology, outcome assessment (clinical vs. imaging), and grading scales. This review also highlights this extreme heterogeneity in the literature of the sclerotherapy outcome and summarizes a few national and international studies for comparison.

show abstract

Treatment of venous malformations: First experience with a new sclerosing agent – A multicenter study

Cited by 29 publications

References 18 publications

Japanese Clinical Practice Guidelines for Vascular Anomalies 2017

Japanese Clinical Practice Guidelines for Vascular Anomalies 2017

Japanese clinical practice guidelines for vascular anomalies 2017

Outcomes of Venous Malformation Sclerotherapy: A Review of Study Methodology and Long-Term Results

Contact Info

Product

Resources

About